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Necrotizing pneumonia caused by Staphylococcus
aureus strains carrying the Panton-Valentin leukocidin
gene is a newly described disease entity. We report a new
fatal case of necrotizing pneumonia. An S. aureus strain
with an agr1 allele and of a new sequence type 377 was
recovered, representing a new, emerging, community-
acquired methicillin-resistant clone.
N
ecrotizing pneumonia associated with Panton-
Valentine leukocidin (PVL) is a recent described clin-
ical entity. It mainly occurs in children and young adults
(median age 15 years), is fatal in 75% of cases, and is asso-
ciated with a median survival time of 4 days (1).
Necrotizing pneumonia is often preceded by a viral-like
illness with signs of rhinopharyngitis. Viruses such as the
influenza A virus have been isolated concomitantly with
the PVL-positive S. aureus (1). Clinically, necrotizing
pneumonia is mainly characterized by a rapidly extensive
pneumonia often associated with pleural effusion and pro-
gressing towards the acute respiratory distress syndrome.
Major associated signs include hemoptysis and leukopenia
(<2 × 109/L) (1). The severity of necrotizing pneumonia
could be due to the products of the PVL genes, which are
present in all S. aureus strains associated with this disease.
The precise pathophysiology of the disease is unknown,
but PVL causes tissue necrosis and leukocyte destruction.
This toxin has been linked to primary skin and soft-tissue
infections such as furuncles and abscesses (1).
Necrotizing pneumonia is mainly associated with PVL-
positive methicillin-susceptible Staphylococcus aureus
strains. Only 1 of the 16 cases reported by Gillet et al. (1)
and 6 of the 40 cases of necrotizing pneumonia reported in
the literature were associated with methicillin-resistant
strains (MRSA). These PVL-positive MRSAcorrespond to
clones that have emerged worldwide and cause communi-
ty-acquired (CA) infections in patients with no risk factors.
These CA-MRSA clones have a continent-specific distri-
bution or worldwide distribution described by Vandenesch
et al. (2). CA-MRSA clones that have spread worldwide
share SCCmec type IV, the smallest cassette containing the
mecA gene coding for methicillin resistance. The major
European clone has a sequence type (ST) 80, as deter-
mined by multilocus sequence typing, and an agr (for
accessory gene regulator) allele of type 3. agr is a global
regulator controlling the expression of virulence factors in
S. aureus, and has 4 alleles (3). PVL-positive CA-MRSA
isolated in Australia have an agr type 3 allele and are of
ST30 or ST93. The PVL-positive CA-MRSA isolated in
the United States are ST1 and agr allele type 3, but some
are ST8 or ST59 and agr allele type 1 (2). Here we report
a fatal case of necrotizing pneumonia involving a 59-year-
old woman infected by a new clone of PVL-positive CA-
MRSA.
Case Report
A 59-year-old woman with an unremarkable medical
history was admitted to Limoges University Hospital
(France) in December 2003 for acute respiratory failure.
She had a 3-day history of flulike syndrome with fever,
chills, cough, and myalgia and had been prescribed nons-
teroidal antiinflammatory therapy. On admission, she had
dyspnea, nonproductive cough, and rales in both lungs. Her
arterial pressure was 60/30 mm Hg. Skin rash and diarrhea
were absent. A chest radiograph showed diffuse alveolar
infiltration of both lungs, without pleural effusion.
Laboratory studies showed leukopenia (leukocytes = 1.66 ×
109/L), mild thrombocytopenia (115,000 platelets/mm3),
hypoxemia (PaO2/FiO2 = 61), and lactic acidosis (pH =
7.29, lactates = 4.45 mmol/L). Empirical antibacterial
chemotherapy combining ceftriaxone, ciprofloxacin, and
gentamicin was started on admission, and mechanical ven-
tilation was immediately necessary. Repeated tracheal aspi-
ration was highly productive and showed hemoptysis and
sustained intraalveolar plasma leakage. Despite fluid resus-
citation, continuous catecholamine perfusion, drotrecogin
alfa (activated) administration (Xigris, Eli Lilly and
Company, Indianapolis, IN, USA), and aggressive care, her
hemodynamic status deteriorated rapidly, leading to multi-
ple organ failure and death <24 hours after admission.
Necropsy showed hemorrhagic foci in both lungs.
Histopathologic studies showed total destruction of the
respiratory epithelium covering the bronchi and bronchi-
oli, together with abundant gram-positive cocci, absence
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of the alveolar septa. These lesions were characteristics of
necrotizing pneumonia. 
S.  aureus was isolated 3 times, by culture of blood
(LIM-48), lung necropsy tissue (LIM-49), and tracheal
aspirate (LIM-50). The 3 isolates had the same antimicro-
bial drug resistance profile (resistant to oxacillin,
kanamycin, tobramycin, and gentamicin) and the same
pattern by pulsed-field gel electrophoresis after DNA
digestion by SmaI (data not shown).
Influenza A virus was detected by polymerase chain
reaction and immunofluorescence on the tracheal aspirate,
but culture on cell lines was negative. The influenza A
virus has been shown to be capable of destroying the res-
piratory epithelium from the trachea to the bronchioli (1),
allowing the PVL-positive CA-MRSA to adhere to the
basement membrane (4). PVL may diffuse locally, attract-
ing polymorphonuclear leukocytes by its chemotactic
activity and lysing them by its leukotoxicity.
Because the clinical manifestations corresponded to
those of necrotizing pneumonia, isolate LIM-49 was
referred (lung necropsy culture) to the French National
Centre for Staphylococci. The isolate was screened for
staphylococcal toxin genes, agr alleles, and the mecA
gene as described elsewhere (Table) (3,5,6). The strain
had an agr type 1 allele and the lukS-PV/lukF-PV genes
encoding PVL (Figure), but harbored no toxin genes (sea
through see, tsst, eta, and etb genes encoding staphylococ-
cal enterotoxins A though E, toxic shock syndrome toxin,
and exfoliative toxins A and B, respectively). The mecA
gene was detected, together with SCCmec type V as
described by Ito et al. (7). The spa type was 355 and the
sequence type was ST377 (Figure). The single nucleotide
difference between ST152 and ST377, which is not distin-
guished by using the usual primers determined by Enright
et al. (8), was established as ST377 by using in-house
primers (forward 5′-ggA CgA Agg TCA TgA TgT ATT
TTT-3′ (nt 327–350), reverse 5′-CTT CTACgC gCT CTC
TTT TTAAg-3′ (nt 564–586), according to the GenBank
ID11211186 of the gmk gene) to amplify appropriate frag-
ment. To our knowledge, this is the first description of
such a necrotizing pneumonia–associated CA-MRSA
clone. Three other ST377 strains were referred to the
National Reference Centre for staphylococci in 2003. Two
were isolated from patients in Europe (Netherlands and
Switzerland), and 1 from an Australia patient (strain pro-
vided by G. Nimmo). The patient from the Netherlands
had been treated for an abscess from which PVL-MRSA
was cultured, and the Swiss patient had furunculosis. The
3 isolates harbored the SCCmec type V cassette, an agr1
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pattern, spa type, as our isolate (Figure).
Conclusions
We report the identification of a new, emerging, highly
virulent PVL-positive CA-MRSA clone that harbors the
SCCmec type V cassette. This tends to confirm the contin-
uing emergence of new CA-MRSA clones. The new clone
seems to have spread rapidly in Europe, because it has
been detected in patients in the Netherlands, Switzerland,
and now in France. Since necrotizing pneumonia is rapid-
ly fatal, as in the patient described here, cases of PVL-pos-
itive CA-MRSA infection must be recognized rapidly,
especially in case of methicillin resistance. The therapeu-
tic value of intravenous immunoglobulin containing anti-
PVL antibodies has been reported by Gauduchon et al. (9)
but must be confirmed.
Dr Garnier is a medical microbiologist at the Limoges
Teaching Hospital, France. His research interests include molec-
ular bacterial identification and bacterial resistance.
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Figure. Pulsed-field gel electrophoresis (PFGE) pattern and phylo-
genetic tree of 4 strains ST377. SmaI macrorestriction patterns
were digitized and analyzed by using GelCompar II (Applied
Maths, Kortrijk, Belgium) to calculate Dice coefficients of correla-
tion and to generate a dendrogram by the unweighted pair group
method using arithmetic averages clustering. The scale indicates
the level of pattern similarity. PVL, Panton-Valentine leukocidin;
ST, sequence type
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